260 related articles for article (PubMed ID: 29378038)
1. Cashew Nut Consumption Increases HDL Cholesterol and Reduces Systolic Blood Pressure in Asian Indians with Type 2 Diabetes: A 12-Week Randomized Controlled Trial.
Mohan V; Gayathri R; Jaacks LM; Lakshmipriya N; Anjana RM; Spiegelman D; Jeevan RG; Balasubramaniam KK; Shobana S; Jayanthan M; Gopinath V; Divya S; Kavitha V; Vijayalakshmi P; Bai R MR; Unnikrishnan R; Sudha V; Krishnaswamy K; Salas-Salvadó J; Willett WC
J Nutr; 2018 Jan; 148(1):63-69. PubMed ID: 29378038
[TBL] [Abstract][Full Text] [Related]
2. Cashew consumption reduces total and LDL cholesterol: a randomized, crossover, controlled-feeding trial.
Mah E; Schulz JA; Kaden VN; Lawless AL; Rotor J; Mantilla LB; Liska DJ
Am J Clin Nutr; 2017 May; 105(5):1070-1078. PubMed ID: 28356271
[No Abstract] [Full Text] [Related]
3. Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial.
Mukuddem-Petersen J; Stonehouse Oosthuizen W; Jerling JC; Hanekom SM; White Z
Br J Nutr; 2007 Jun; 97(6):1144-53. PubMed ID: 17381974
[TBL] [Abstract][Full Text] [Related]
4. The effects of cashew nut intake on lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled trials.
Jalali M; Karamizadeh M; Ferns GA; Zare M; Moosavian SP; Akbarzadeh M
Complement Ther Med; 2020 May; 50():102387. PubMed ID: 32444052
[TBL] [Abstract][Full Text] [Related]
5. Consumption of cashew nuts does not influence blood lipids or other markers of cardiovascular disease in humans: a randomized controlled trial.
Baer DJ; Novotny JA
Am J Clin Nutr; 2019 Feb; 109(2):269-275. PubMed ID: 30753323
[TBL] [Abstract][Full Text] [Related]
6. Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome.
Schutte AE; Van Rooyen JM; Huisman HW; Mukuddem-Petersen J; Oosthuizen W; Hanekom SM; Jerling JC
Am J Hypertens; 2006 Jun; 19(6):629-36. PubMed ID: 16733237
[TBL] [Abstract][Full Text] [Related]
7. Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial.
Jenkins DJA; Kendall CWC; Lamarche B; Banach MS; Srichaikul K; Vidgen E; Mitchell S; Parker T; Nishi S; Bashyam B; de Souza RJ; Ireland C; Pichika SC; Beyene J; Sievenpiper JL; Josse RG
Diabetologia; 2018 Aug; 61(8):1734-1747. PubMed ID: 29789878
[TBL] [Abstract][Full Text] [Related]
8. The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial.
Fuller NR; Caterson ID; Sainsbury A; Denyer G; Fong M; Gerofi J; Baqleh K; Williams KH; Lau NS; Markovic TP
Am J Clin Nutr; 2015 Apr; 101(4):705-13. PubMed ID: 25833969
[TBL] [Abstract][Full Text] [Related]
9. Effect of pistachio consumption on plasma lipoprotein subclasses in pre-diabetic subjects.
Hernández-Alonso P; Salas-Salvadó J; Baldrich-Mora M; Mallol R; Correig X; Bulló M
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):396-402. PubMed ID: 25791863
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of a beverage containing Brazil and cashew nuts on oxidative stress, lipemia, and blood pressure of women with cardiometabolic risk (Brazilian Nuts Study): a randomized clinical trial.
Bonifácio DB; Caldas APS; Costa MAC; Rocha DMUP; Hermsdorff HHM; Bressan J
Appl Physiol Nutr Metab; 2023 Oct; 48(10):789-798. PubMed ID: 37311253
[TBL] [Abstract][Full Text] [Related]
11. Do dry roasting, lightly salting nuts affect their cardioprotective properties and acceptability?
Tey SL; Robinson T; Gray AR; Chisholm AW; Brown RC
Eur J Nutr; 2017 Apr; 56(3):1025-1036. PubMed ID: 26746221
[TBL] [Abstract][Full Text] [Related]
12. Nuts and Cardio-Metabolic Disease: A Review of Meta-Analyses.
Kim Y; Keogh J; Clifton PM
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563231
[TBL] [Abstract][Full Text] [Related]
13. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes.
Mansour A; Mohajeri-Tehrani MR; Qorbani M; Heshmat R; Larijani B; Hosseini S
Nutrition; 2015 Jan; 31(1):119-26. PubMed ID: 25466655
[TBL] [Abstract][Full Text] [Related]
14. Nut consumption, serum fatty acid profile and estimated coronary heart disease risk in type 2 diabetes.
Nishi SK; Kendall CW; Bazinet RP; Bashyam B; Ireland CA; Augustin LS; Blanco Mejia S; Sievenpiper JL; Jenkins DJ
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):845-52. PubMed ID: 24925120
[TBL] [Abstract][Full Text] [Related]
15. Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: a randomized crossover trial.
Parham M; Heidari S; Khorramirad A; Hozoori M; Hosseinzadeh F; Bakhtyari L; Vafaeimanesh J
Rev Diabet Stud; 2014; 11(2):190-6. PubMed ID: 25396407
[TBL] [Abstract][Full Text] [Related]
16. The effect of tree nut, peanut, and soy nut consumption on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials.
Mohammadifard N; Salehi-Abargouei A; Salas-Salvadó J; Guasch-Ferré M; Humphries K; Sarrafzadegan N
Am J Clin Nutr; 2015 May; 101(5):966-82. PubMed ID: 25809855
[TBL] [Abstract][Full Text] [Related]
17. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials.
Sabaté J; Oda K; Ros E
Arch Intern Med; 2010 May; 170(9):821-7. PubMed ID: 20458092
[TBL] [Abstract][Full Text] [Related]
18. Cashew nuts (Anacardium occidentale L.) decrease visceral fat, yet augment glucose in dyslipidemic rats.
Dias CCQ; Madruga MS; Pintado MME; Almeida GHO; Alves APV; Dantas FA; Bezerra JKG; de Melo MFFT; Viera VB; Soares JKB
PLoS One; 2019; 14(12):e0225736. PubMed ID: 31830056
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women.
Khaw KT; Sharp SJ; Finikarides L; Afzal I; Lentjes M; Luben R; Forouhi NG
BMJ Open; 2018 Mar; 8(3):e020167. PubMed ID: 29511019
[TBL] [Abstract][Full Text] [Related]
20. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
Sacks FM; Carey VJ; Anderson CA; Miller ER; Copeland T; Charleston J; Harshfield BJ; Laranjo N; McCarron P; Swain J; White K; Yee K; Appel LJ
JAMA; 2014 Dec; 312(23):2531-41. PubMed ID: 25514303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
